Cinqair

Black-and-white image of a thumbs-up hand and a thumbs-down hand in front of a blank wall

Which asthma biologic is the most popular of them all?

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.

Angus Liu Nov 21, 2019 11:35am

Novartis

Novartis' Xolair eyes sinusitis to backstop blockbuster sales

Jun 4, 2019 12:51pm

Sanofi

Sanofi's Dupixent set for $2.5B in peak asthma sales: analyst

Oct 22, 2018 12:40pm

dupixent

5 antibody drugs for asthma show benefits but cost too much—ICER

Sep 26, 2018 12:11pm

AstraZeneca

AZ, shut out of COPD, touts long-term Fasenra asthma data

Sep 18, 2018 11:01am

Teva

Flopped trials dash Teva's hopes for subcutaneous Cinqair

Jan 22, 2018 10:32am